By Holly Beilin
Over 250 million people suffer from ailments where medical cannabis products have proven to help alleviate pain or suffering. A large portion of this audience lives in emerging markets — states where medical cannabis has only been legalized in the last few years.
Georgia is one such state, legalizing the use of low-THC cannabis oil for patients with a limited list of conditions such as Parkinson’s Disease, cancer and seizure disorders in 2015. In 2017, Gov. Nathan Deal added to that list of medical ailments.
And, out of the 15,000 total patients in Georgia that have successfully received a recommendation card from a doctor that allows them to possess these products, one startup has helped shepherd 1,500 of them — 10 percent — through the process.
Brandon Terrell was working for a startup in North Carolina that was acquired the same year that Georgia legislators passed medical marijuana legislation. He was pondering his next move and noticed the challenges the emerging cannabis industry was facing — specifically, the difficulty providers had connecting with patients, and vice versa.
To do his research, he went to markets where the industry was much more established.